News
2018
Sustained Virologic Response reduces the Incidence of Extrahepatic Manifestations in Chronic Hepatitis C Infection
AASLD Conference reports for NATAP
The Impact of Sustained Virological response to HCV infection on long term risk of infection of hepatocellular carcinoma – The BC Hepatitis Testers Cohort
AASLD Conference reports for NATAP
The Impact of HCV SVR from direct acting antiviral and interferon-based treatments on mortality in a large population based cohort study
AASLD Conference reports for NATAP
Hepatitis Debrief: The Liver Meeting 2018
AASLD Conference reports for NATAP
HCV Re-infection in people with High-risk Behaviour Low
by AGA Reading Room
Alcohol use disorder compromises benefits of DAA therapy for HCV
by Healio
Global Health Sector on Viral Hepatitis: What does this mean for Canadians?
by CATIE
2017
New Research underlines need to develop a hepatitis C vaccine
by UBC Medicine
Fast Facts: Hepatitis C treatment cascade and developments in access to treatment
by CATIE
Previously Cured HCV Patients Can Be Reinfected- Prevention will require attention to high-risk behaviors
by Medpage Today
HCV Rare in Kids; Treatment Isn’t straightforward- DAAs may be around the corner for children, but many considerations
by Medpage Today
Late Diagnosis of hepatitis C in people with advanced liver injury decreasing in B.C.
by CATIE Hep C info
The Power of Health Research
by CIHR
SPPH Post- doctoral fellows win Banting, MSFHR Award
by SPPH
Looking at the Twin Epidemics of HCV
by MedPage Today
HCV Moving closer to Eradication- funding, lower drug costs could win fight against HCV
by MedPage Today
Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study.
by HCV Trials (expert commentary)
The Hepatitis C Care Cascade: From Diagnosis to Care and Treatment in British Columbia
by Pacific Aids Network
Treatment and Reinfection for Hepatitis C Treatment: The Lancet Gastroenterology & Hepatology
by Lancet Podcast
Opoid Addiction Treatment and Psychotherapy Tied to Less HIV Risk in Those with Hepatitis C
by Hep Magazine
Counselling and opioid subsititution therapy could reduce risk of hepatitis C reinfection
by UBC Medicine
2016
Targeted services needed to prevent new Hep C infections
by School of Population & Public Health, University of British Columbia
Twin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis Testers Cohort
by MDLinx
Liver Cancer Risk Reduced After Hepatitis C Treatment, But Vigilance Needed
by HIV and Hepatitis
DAA treatment reduces risk of HCC for most hepatitis C patients
by Medical Brief
SVR Post-interferon-based-therapy reduces, not eliminates risk of HCC
by Healio
Liver Cancer Risk Reduced after Hepatitis C treatment, but vigilance needed
by Eat.org
Incidence, Risk Factors and Prevention of Hepatitis C Reinfection
by Medical Research
Highs and No Lows
by Valley Voice
BCCDC Publishes New Findings – Listen to Simi Samra
by Simi Samra Show CNKW AM980